Pre-market
PME for Tissue and Cell Management System
- King's College Hospital NHS Foundation Trust
- London
- 3 May 2027 to 2 May 2032
End-to-end management and traceability of cellular therapy products from donor and patient registration through collection, processing, cryopreservation, storage, issue and administration. Requirements include ISBT 128 labelling, a secure audit trail, quality management of deviations and non-conformances, inventory and storage location management, and reporting. Suppliers must support IQ/OQ/PQ validation before go-live and controlled post-go-live upgrades. Deployment may be on Microsoft-based on-premise infrastructure, supplier-hosted, or cloud/SaaS, and Epic interfaces are of interest.
Due in 4 days· 26 Nov 2026
- What
- Public sector
- Buyer
- King's College Hospital NHS Foundation Trust
- Estimated value
- £375,000
- How it will be bought
- Not published
- Responses due
- 26 Nov 2026
- Contract dates
- May 2027 to May 2032